HEMOBLAST Bellows
FDA premarket approval P170012/S027 · decided 2021-10-13
Approval details
- PMA number
- P170012
- Supplement
- S027
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- HEMOBLAST Bellows
- Generic name
- Absorbable collagen hemostatic agent with thrombin
- Applicant
- Dilon Technologies, Inc.
- Date received
- 2021-09-13
- Decision date
- 2021-10-13
- Days to decision
- 30 days
- Decision code
- OK30
- Product code
- PMX
- Advisory committee
- General, Plastic Surgery
- Expedited review
- No
- Location
- Newport News, VA
- Statement
- Change the location of performing Differential Scanning Calorimetry testing on the finished HEMOBLAST Bellows hemostatic powder to Biom'Up's manufacturing facility in St-Priest, France.
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.
510(k) clearances by this applicant
| Record | Firm | Date |
|---|---|---|
| DILON 6800 ACELLA (ACELLA) (K110384) | Dilon Technologies, Inc. | 2011-05-03 |
| DILON 2000, MODEL 2000-6X8 AND DILON 2000, MODEL 2000-5X5 (K984466) | Dilon Technologies, Inc. | 1999-03-16 |